Search results
Here's the skinny: Diabetes drug Ozempic is hugely popular as a weight loss wonder
Pittsburgh Tribune-Review· 10 hours agoFor Diane Lang, the big push to focus on her health and weight came from her grandchildren. Lang, of...
EXCLUSIVE: Vivani Medical's Type 2 Diabetes Treatment NPM-119 Subdermal Implant's IND Gains FDA...
Benzinga via AOL· 6 hours agoFDA has cleared its Investigational New Drug Application for NPM-119, paving the way for the...
New KFF Analysis Finds Costly GLP-1 Drugs ( includes Wegovy and Ozempic) are Rarely Covered for...
Sierra Sun Times· 7 hours ago(ACA) Marketplace plans rarely cover GLP-1 drugs approved solely for obesity treatment, according to a new KFF analysis of 2024 federal plan data. Wegovy, a drug& ...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 28 minutes agoThe drug, now known as Casgevy, will cost $2.2 million for a single treatment. But uptake remains to...
Vivani Medical Shares Up, FDA Cleared New Drug Application to Start Diabetes Trial
Morningstar· 5 hours agoBy Sabela Ojea Shares of Vivani Medical on Thursday climbed after the company said that the Food and Drug Administration cleared its investigational new drug</ ...
High price of popular diabetes drugs deprives low-income people of effective treatment
Daily Montanan via Yahoo News· 5 days agoWithout Ozempic or a similar drug, Cooper Harris suffers blackouts, becomes too tired to watch her...
Michigan’s largest insurer to drop weight-loss drug coverage
Chicago Tribune· 1 day agoWeight-loss drugs from Novo Nordisk A/S and Eli Lilly & Co. will lose coverage under many plans run...
AstraZeneca's Farxiga Approved For Treating Pediatric Type-2 Diabetes in U.S.
Morningstar· 22 hours agoAstraZeneca's diabetes drug Farxiga on Wednesday was approved by U.S. regulators for the treatment of type-2 diabetes
FDA approves AstraZeneca’s Farxiga for paediatric T2D patients
Pharmaceutical Technology via Yahoo Finance· 12 hours agoThe US Food and Drug Administration (FDA) has granted approval for AstraZeneca's Farxiga...
Diabetic woman's six-month meds shortage struggle
BBC News· 7 hours agoA diabetic woman from Birmingham has said she has struggled to get her much-needed medication for the past six months after global supply shortages meant...